fda warning letters compounded semaglutide 2025 Peptide boom has states scrambling to protect consumers, Post investigation finds There's lots going on this

One of the most significant concerns involves changes in saliva production and composition

Includes: 5 Learning Modules, 12 Week Guided Action Plan, Recipes, Meal Plans, Resources & Tracking Tools 3I Framework for Mindset & Goal Setting Biofeedback & The 4Ps: Customize for Your Body & Your Lifestyle The Health First Approach to Metabolism Mindful & Intuitive Eating The AIM Method: Awareness, Adaptation & Integration 12 Week Guided Action Plan: Build Your Wellness Roadmap Recipes & Meal Plans: 650+ Recipes & Meal Plans Tools & Resources - Habit trackers, reflection exercises, and implementation guides

Semaglutide, a GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management, works by activating brain receptors that regulate hunger and slowing gastric emptying

"We also found that the risk for GERD was higher with long-acting GLP-1 (drug) use," researchers wrote